Clinical Trials
0
0 active
Approvals
3
Total approvals
Agencies
1
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No trial data available
<p><strong>Therapeutic indications</strong><br> SEROQUEL XR is indicated for the treatment of schizophrenia.<br> SEROQUEL XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on SEROQUEL XR.<br> SEROQUEL XR is indicated for bipolar disorder:</p> <ul class="dash"> <li>manic episodes associated with bipolar I disorder</li> <li>depressive episodes associated with bipolar disorder</li> <li>preventing recurrence in maintenance treatment of bipolar disorder (manic, mixed or depressive episode) as monotherapy or in combination with lithium or valproate.</li> </ul> <p>SEROQUEL XR is indicated for use as add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of SEROQUEL XR.</p>
<p><strong>Therapeutic indications</strong><br> SEROQUEL XR is indicated for the treatment of schizophrenia.<br> SEROQUEL XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on SEROQUEL XR.<br> SEROQUEL XR is indicated for bipolar disorder:</p> <ul class="dash"> <li>manic episodes associated with bipolar I disorder</li> <li>depressive episodes associated with bipolar disorder</li> <li>preventing recurrence in maintenance treatment of bipolar disorder (manic, mixed or depressive episode) as monotherapy or in combination with lithium or valproate.</li> </ul> <p>SEROQUEL XR is indicated for use as add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of SEROQUEL XR.</p>
<p><strong>Indications</strong><br> SEROQUEL is indicated for the treatment of:</p> <ul> <li>schizophrenia.</li> <li>acute manic episodes associated with bipolar I disorder.</li> <li>depressive episodes associated with bipolar disorder.</li> <li>preventing recurrence in maintenance treatment of bipolar I disorder (manic, mixed or depressive episode) as monotherapy or in combination with lithium or valproate.</li> </ul>
No news articles found